Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ml355
2. N-(1,3-benzothiazol-2-yl)-4-((2-hydroxy-3-methoxyphenyl)methylamino)benzenesulfonamide
1. Ml355
2. 1532593-30-8
3. Ml355 Free Base
4. Ml-355
5. Vlx-1005
6. Jku4xcc48y
7. Chembl3113165
8. N-(benzo[d]thiazol-2-yl)-4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide
9. Benzenesulfonamide, N-2-benzothiazolyl-4-(((2-hydroxy-3-methoxyphenyl)methyl)amino)-
10. N-2-benzothiazolyl-4-(((2-hydroxy-3-methoxyphenyl)methyl)amino)benzenesulfonamide
11. N-2-benzothiazolyl-4-[[(2-hydroxy-3-methoxyphenyl)methyl]amino]-benzenesulfonamide
12. Ncgc00263773-03
13. N-2-benzothiazolyl-4-[[(2-hydroxy-3-methoxyphenyl)methyl]amino]benzenesulfonamide
14. Unii-jku4xcc48y
15. Gtpl8752
16. Schembl16646023
17. Bcp28954
18. Ex-a1987
19. Bdbm50447175
20. Ml 355
21. S6557
22. Ml 355;ml-355
23. Zinc103266485
24. Cs-3351
25. Ncgc00263773-01
26. Ncgc00263773-18
27. Ac-36858
28. Bs-15552
29. Hy-12341
30. B8014
31. A908037
32. Q27087172
33. N-(2-benzothiazolyl)-4-(2-hydroxy-3-methoxybenzylamino)benzenesulfonamide
34. N-(benzo[d]thiazol-2-yl)-4-(2-hydroxy-3-methoxybenzylamino)benzenesulfonamide
35. Ml-355; Ml-355;n-(benzo[d]thiazol-2-yl)-4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide
| Molecular Weight | 441.5 g/mol |
|---|---|
| Molecular Formula | C21H19N3O4S2 |
| XLogP3 | 4.3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 7 |
| Exact Mass | 441.08169844 g/mol |
| Monoisotopic Mass | 441.08169844 g/mol |
| Topological Polar Surface Area | 137 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 651 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
30
PharmaCompass offers a list of VLX-1005 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right VLX-1005 manufacturer or VLX-1005 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred VLX-1005 manufacturer or VLX-1005 supplier.
PharmaCompass also assists you with knowing the VLX-1005 API Price utilized in the formulation of products. VLX-1005 API Price is not always fixed or binding as the VLX-1005 Price is obtained through a variety of data sources. The VLX-1005 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A ML355 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ML355, including repackagers and relabelers. The FDA regulates ML355 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ML355 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A ML355 supplier is an individual or a company that provides ML355 active pharmaceutical ingredient (API) or ML355 finished formulations upon request. The ML355 suppliers may include ML355 API manufacturers, exporters, distributors and traders.
ML355 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ML355 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ML355 GMP manufacturer or ML355 GMP API supplier for your needs.
A ML355 CoA (Certificate of Analysis) is a formal document that attests to ML355's compliance with ML355 specifications and serves as a tool for batch-level quality control.
ML355 CoA mostly includes findings from lab analyses of a specific batch. For each ML355 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ML355 may be tested according to a variety of international standards, such as European Pharmacopoeia (ML355 EP), ML355 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ML355 USP).
